Novo Nordisk CEO Jørgensen aims to leverage diabetes know-how, deals into the new decade

Novo Nordisk, the world's biggest insulin producer, has set itself an unaccustomed task: Expand not just within diabetes, but beyond. Wednesday, executives outlined just how they plan to do that—and how they plan to measure its progress on the way.